REACTIVITY TO HUMAN ISLETS AND FETAL PIG PROISLETS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM SUBJECTS WITH PRECLINICAL AND CLINICAL INSULIN-DEPENDENT DIABETES

Harrison, LC; DeAizpurua, H; Loudovaris, T; CAMPBELL, IL; Cebon, JS; Tait, BD; Colman, PG

Author(s): Harrison, LC; DeAizpurua, H; Loudovaris, T; CAMPBELL, IL; Cebon, JS; Tait, BD; Colman, PG;
Details: Publication Year 1991-09,Volume 40,Issue #9,Page 1128-1133
Journal Title: DIABETES
Publication Type: Journal Article
Abstract: A simple, direct assay for T-lymphocyte reactivity to islet antigen(s) in human insulin-dependent diabetes mellitus (IDDM) should facilitate preclinical diagnosis and the evaluation of intervention therapy to avert autoimmune-mediated beta-cell destruction. In subjects with preclinical or clinical IDDM, we measured the reactivity of peripheral blood mononuclear cells (PBMCs) incubated over 6 days with either adult human islets or fetal pig proislets, or other fetal pig tissues, and with human insulin. With islets, the stimulation index (SI) of [H-3]thymidine uptake by PBMCs exceeded the mean + 2SD of control subjects in 6 of 6 preclinical subjects (SI 8.7 +/- 3.7), 7 of 11 clinical subjects (SI 5.2 +/- 3.4), and 1 of 12 control subjects (SI 2.7 +/- 1.7); with insulin, the responses were less in frequency and magnitude, being 4 of 6 (2.7 +/- 1.6), 3 of 11 (2.2 +/- 1.1), and 0 of 12 (1.20 +/-0.55), respectively. The mean responses to islets of PBMCs from preclinical and clinical subjects differed significantly from control subjects (P < 0.02 by 2-tailed Kruskal-Wallis test). Secretion of granulocyte macrophage colony-stimulating factor by PBMCs over 6 days was assayed in the preclinical group and generally paralleled the uptake of [H-3]thymidine. PBMC reactivity to islets appeared to be at least as sensitive a marker of preclinical IDDM as autoantibodies to a 64,000-M(r) protein, presumably the enzyme glutamic acid decarboxylase, in fetal pig proislets. In conclusion, islet-reactive T lymphocytes in subjects with preclinical and clinical IDDM can be identified in bulk culture of PBMCs. Detection of these autoreactive T lymphocytes should be of value in the diagnosis of preclinical IDDM and in monitoring the effects of immunotherapy.
Publisher: AMER DIABETES ASSOC
Keywords: HIGH-RISK; T-CELLS; MELLITUS; PANCREAS; DECARBOXYLASE; SPECIFICITY; ANTIBODIES; INVITRO; CLONES; RAT
Publisher's Version: https://doi.org/10.2337/diabetes.40.9.1128
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 1991-09-01 12:00:00